8-KFinancial EventsOther EventsExhibits & Filings

Elevance Health, Inc. 8-K Report, Financial Obligation (Aug 15, 2011)

Filed August 15, 2011For Securities:ELV

Summary

Elevance Health, Inc., then operating as WellPoint, Inc., filed this Form 8-K on August 15, 2011, to report on the successful completion of a significant debt offering. The company issued $400 million in 2.375% Notes due 2017 and $700 million in 3.700% Notes due 2021, raising a total of approximately $1.09 billion in net proceeds after offering expenses. The proceeds from this debt issuance are earmarked for general corporate purposes, including working capital and the repayment of existing debt. Notably, a portion of these funds may also be allocated to finance the pending acquisition of CareMore Health Group, signaling strategic growth initiatives. The filing also details the terms of the new notes, including interest payment schedules, maturity dates, and provisions for early redemption by the company, as well as circumstances that could trigger an accelerated repurchase obligation by the company in the event of a change of control coupled with a credit rating downgrade.

Key Highlights

  • 1WellPoint, Inc. (now Elevance Health) completed a debt offering totaling $1.1 billion on August 15, 2011.
  • 2The offering consisted of $400 million of 2.375% Notes due 2017 and $700 million of 3.700% Notes due 2021.
  • 3Net proceeds from the offering were approximately $1.09 billion.
  • 4Proceeds are designated for working capital, general corporate purposes, and debt repayment.
  • 5A portion of the proceeds may be used to fund the pending acquisition of CareMore Health Group.
  • 6The new notes have specific maturity dates (2017 and 2021) and semi-annual interest payment schedules.
  • 7The debt agreement includes provisions for early redemption by the company and a potential change-of-control repurchase obligation.

Frequently Asked Questions

The primary purpose of this 8-K filing was to report the creation of a direct financial obligation resulting from the company's issuance and sale of $1.1 billion in aggregate principal amount of new senior notes.

WellPoint, Inc. raised approximately $1.09 billion in net proceeds from the sale of $400 million of 2.375% Notes due 2017 and $700 million of 3.700% Notes due 2021. The funds are intended for working capital, general corporate purposes, repayment of debt, and potentially to finance the acquisition of CareMore Health Group.

The company issued two series of notes: $400 million of 2.375% Notes due February 15, 2017, and $700 million of 3.700% Notes due August 15, 2021. Interest on both notes is payable semi-annually.

Yes, under certain conditions, WellPoint, Inc. would be required to make an offer to repurchase all of the notes. This would occur upon the occurrence of both a change of control of the company and a downgrade of the notes below an investment grade rating by Moody's, S&P, and Fitch within a specified period. The repurchase price would be 101% of the principal amount plus accrued interest.